How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

228 results for

Pityriasis Rosea

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

221. Pityriasis Rosea

Pityriasis Rosea Pityriasis Rosea. Causes and pityriasis rosea treatment | Patient TOPICS Try our Symptom Checker TREATMENT RESOURCES Try our Symptom Checker PROFESSIONAL Upgrade to Patient Pro / / Search Pityriasis Rosea Authored by , Reviewed by | Last edited 27 Jul 2016 | Certified by This article is for Medical Professionals Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines (...) . You may find the article more useful, or one of our other . In this article In This Article Pityriasis Rosea In this article Pityriasis rosea is an acute, self-limiting skin condition. A primary plaque ('herald patch') is followed by a distinctive, generalised itchy rash 1-2 weeks later. The rash typically lasts for approximately 5-8 weeks. Lesions are typically oval, dull pink or tawny and appear in a 'Christmas tree' distribution, usually on the trunk and the upper arms and legs. Aetiology

2008 Mentor

222. Is there any evidence that pityriasis rosea in a 32 week primip would cause problems?

Is there any evidence that pityriasis rosea in a 32 week primip would cause problems? Is there any evidence that pityriasis rosea in a 32 week primip would cause problems? - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing (...) including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com Is there any evidence that pityriasis rosea in a 32 week primip would cause problems? The American Academy of Dermatology has a pamphlet on pityriasis rosea in which they note: " Patients should be reassured that this disease

2003 TRIP Answers

223. A Remarkable Result of a Double-Masked, Placebo-Controlled Trial of Erythromycin in the Treatment of Pityriasis Rosea. (Abstract)

A Remarkable Result of a Double-Masked, Placebo-Controlled Trial of Erythromycin in the Treatment of Pityriasis Rosea. 10871946 2000 06 28 1538-3652 136 6 2000 Jun Archives of dermatology Arch Dermatol A Remarkable Result of a Double-Masked, Placebo-Controlled Trial of Erythromycin in the Treatment of Pityriasis Rosea. 775-776 Bigby M Editor. eng Journal Article United States Arch Dermatol 0372433 0003-987X 2000 6 29 2000 6 29 2000 6 29 0 0 ppublish 10871946 ded0775

2000 Archives of Dermatology Controlled trial quality: uncertain

224. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Full Text available with Trip Pro

Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Sixteen cases of either a pityriasiform or discoid eczematous rash occurring in patients with rheumatoid arthritis receiving treatment with gold (sodium aurothiomalate and auranofin) were studied. The results suggest that this is a dose related, not allergic, reaction to gold. The development of this rash is not an absolute indication to stop treatment with gold. Control can often be effected with potent topical

1992 Annals of the Rheumatic Diseases

225. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. (Abstract)

Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. The study stemmed from an incidental observation of improvement in 2 patients with pityriasis rosea while receiving erythromycin.The purpose of the study was to evaluate the efficacy of erythromycin in patients with pityriasis rosea.A double-blind, placebo-controlled clinical study was performed in an outpatient setting in a major hospital. Ninety patients over a period of 2 years were alternatively assigned (...) response was observed in 33 patients (73.33%) in the treatment group and none in the placebo group (P <.0001).Oral erythromycin was effective in treating patients with pityriasis rosea.

2000 Journal of the American Academy of Dermatology Controlled trial quality: uncertain

226. Atypical pityriasis rosea or psoriasis guttata? Early examination is the key to a correct diagnosis. (Abstract)

Atypical pityriasis rosea or psoriasis guttata? Early examination is the key to a correct diagnosis. Pityriasis rosea is a self-limited, mild, inflammatory skin disease characterized by scaly lesions, possibly due to an unidentified infectious agent. It may occur at any age, but is seen most frequently in young adults. This paper reports a patient who presented with a skin condition which was initially diagnosed as pityriasis rosea; however, due to the persistence and change in appearance (...) of the lesions, the diagnosis was later altered to psoriasis guttata. Changes in pityriasis rosea lesions over the course of the disease may make a correct diagnosis difficult, unless the patient is seen during the early stages of lesion formation. The final diagnosis in this case was of the rare variant known as pityriasis rosea irritata. This case highlights the importance of an excellent patient history in order to correctly diagnose the disease.

2002 International Journal of Dermatology

227. Detection of human herpesvirus 7 in pityriasis rosea by nested PCR. (Abstract)

Detection of human herpesvirus 7 in pityriasis rosea by nested PCR. Clinical presentation, immunologic, light microscopic, and electron microscopic studies suggest a viral etiology for pityriasis rosea (PR).To evaluate whether human herpesvirus 7 (HHV-7) is an etiologic factor for PR.Twenty-one PR patients (12 female, nine male) aged between 12 and 52 years, whose diagnoses were confirmed clinically and histopathologically, were included in the study. The duration of the disease was questioned

2002 International Journal of Dermatology

228. Case clustering in pityriasis rosea: a multicenter epidemiologic study in primary care settings in Hong Kong. Full Text available with Trip Pro

Case clustering in pityriasis rosea: a multicenter epidemiologic study in primary care settings in Hong Kong. To investigate the epidemiology of pityriasis rosea in primary care settings in Hong Kong and to analyze for temporal clustering.Retrospective epidemiologic study.Six primary care teaching practices affiliated with a university. Patients Forty-one patients with pityriasis rosea, 564 patients with atopic dermatitis (negative control condition), and 35 patients with scabies (positive (...) control condition).We retrieved all records of patients with pityriasis rosea, atopic dermatitis, or scabies diagnosed in 3 years. We analyzed temporal clustering by a method based on a regression model.The monthly incidence of pityriasis rosea is negatively but insignificantly correlated with mean air temperature (gamma s = -0.41, P =.19) and mean total rainfall (gamma s = -0.34, P =.27). Three statistically significant clusters with 7, 6, and 7 cases were identified (P =.03), occurring in the second

2003 Archives of Dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>